等待開盤 09-24 09:30:00 美东时间
-0.120
-0.11%
今日重点评级关注:Citizens:上调Quince Therapeutics评级至"跑赢大市",目标价77美元;康托·菲茨杰拉德:维持塞德斯医疗"超配"评级,目标价从61美元升至72美元
09-23 15:30
今日重点评级关注:HC Wainwright & Co.:维持Gossamer Bio"买入"评级,目标价从2美元升至90美元;巴克莱:维持Ultragenyx Pharmaceutical"超配"评级,目标价从32美元升至35美元
09-22 16:25
Citizens analyst Andrew Boone reiterates Xometry (NASDAQ:XMTR) with a Market Outperform and maintains $120 price target.
09-21 20:55
Xometry launched its next-gen Workcenter platform, enhancing job discovery, performance tracking, and payment visibility for manufacturing partners. The redesigned homepage unifies key metrics and job opportunities, while the rebuilt Job Board reduces review time by over 60% and increases acceptance rates by 15%. Features include a dedicated technical drawing review screen, customizable views, and real-time performance scores. Xometry's AI-native...
09-08 13:05
Xometry, Inc. (NASDAQ: XMTR) announced that its management team will attend two investor events: the Goldman Sachs Communacopia + Technology Conference 2026 on September 8 in San Francisco, featuring a fireside chat at 3:45 p.m. PT, and Citi’s 2026 Global TMT Conference on September 10 in New York City. The fireside chat webcast and replay will be available on Xometry’s Investor Relations website. Xometry’s AI-native marketplace digitizes manufac...
08-25 13:05
今日重点评级关注:Truist Securities:维持CoreWeave"买入"评级,目标价从155美元升至165美元;百德:维持亚德诺"跑赢大市"评级,目标价从450美元升至675美元
08-25 11:47
Shopify Inc. (NASDAQ:SHOP) and Take-Two Interactive Software Inc. (NASDAQ:TTWO) remain JPMorgan’s highest-conviction consumer technology investments, but the New York-based bank says investors shouldn’t overlook a handful of smaller companies benefiting from long-term trends including artificial int...
08-24 21:18
今日重点评级关注:康托·菲茨杰拉德:维持Ultragenyx Pharmaceutical"超配"评级,目标价从96美元升至103美元;Canaccord Genuity:维持Ultragenyx Pharmaceutical"买入"评级,目标价从81美元升至83美元
08-21 11:40
Rosenblatt analyst Scott Devitt initiates coverage on Xometry (NASDAQ:XMTR) with a Buy rating and announces Price Target of $110.
08-20 21:28
今日重点评级关注:HC Wainwright & Co.:维持Precigen"买入"评级,目标价从14美元升至18美元;HC Wainwright & Co.:维持Sophia Genetics"买入"评级,目标价从12美元升至14美元
08-06 11:36